Catalyst Wire Dossier Catalyst Wire Dossier

Lidocaine 2% pharmacopuncture at GB20

lidocaine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lidocaine 2% pharmacopuncture at GB20, covering 2026-01-05 to 2026-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Effectivity and Safety of GB20 Acupoint Pharmacopuncture With Lidocaine 2% on Migraine Patients [NA]

See pricing